» Articles » PMID: 37166492

The Impact of Prior Fragility Fractures on Long-term Periprosthetic Fracture Risk Following Total Knee Arthroplasty

Overview
Journal Osteoporos Int
Date 2023 May 11
PMID 37166492
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to characterize the association of prior FFs on long-term risk of secondary fragility fracture (FF), periprosthetic fracture (PPF), and revision TKA.

Methods: Patients at least 50 years of age who underwent elective TKA were identified in the PearlDiver Database. Patients were stratified based on whether they sustained a FF within 3 years prior to TKA (7410 patients) or not (712,954 patients). Demographics and comorbidities were collected. Kaplan Meier analysis was used to observe the cumulative incidence of all-cause revision, PPF, and secondary FF within 8 years of TKA. Cox Proportional hazard ratio analysis was used to statistically compare the risk.

Results: In total, 1.0% of patients had a FF within three years of TKA. Of these patients, only 22.6% and 10.9% had a coded diagnosis of osteoporosis and osteopenia, respectively, at time of TKA. The 8-year cumulative incidence of secondary FF and periprosthetic fracture was significantly higher in those with a prior FF (27.5% secondary FF and 1.9% PPF) when compared to those without (9.1% secondary FF and 0.7% PPF). After adjusting for covariates, patients with a recent FF had significantly higher risks of secondary FF (HR 2.73; p < 0.001) and periprosthetic fracture (HR 1.86; p < 0.001) than those without a recent FF.

Conclusions: Recent FF before TKA is associated with increased risk for additional FF and PPF within 8 years following TKA. Surgeons should ensure appropriate management of fragility fracture is undertaken prior to TKA to minimize fracture risk, and if not, be vigilant to identify patients with prior FF or other bone health risk factors who may have undocumented osteoporosis.

Citing Articles

Osteoporosis in the setting of knee arthroplasty: a narrative review.

Daher M, Mekhael E, El-Othmani M Arthroplasty. 2024; 6(1):50.

PMID: 39354637 PMC: 11445950. DOI: 10.1186/s42836-024-00273-z.


A Bone Health Optimization Framework for Malaysia: a position paper by the Malaysian Bone Health Optimization Network (MyBONe).

Lee J, Leong J, Thong F, Sharifudin M, Abbas A, Kamudin N Arch Osteoporos. 2024; 19(1):88.

PMID: 39304537 DOI: 10.1007/s11657-024-01448-6.


Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study.

Patel R, Judge A, Johansen A, Javaid M, Griffin X, Chesser T J Bone Miner Res. 2024; 39(8):1071-1082.

PMID: 38988134 PMC: 11337946. DOI: 10.1093/jbmr/zjae100.

References
1.
Sloan M, Premkumar A, Sheth N . Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018; 100(17):1455-1460. DOI: 10.2106/JBJS.17.01617. View

2.
Bernatz J, Brooks A, Squire M, Illgen 2nd R, Binkley N, Anderson P . Osteoporosis Is Common and Undertreated Prior to Total Joint Arthroplasty. J Arthroplasty. 2019; 34(7):1347-1353. DOI: 10.1016/j.arth.2019.03.044. View

3.
Ha C, Park Y . Underestimation and undertreatment of osteoporosis in patients awaiting primary total knee arthroplasty. Arch Orthop Trauma Surg. 2020; 140(8):1109-1114. DOI: 10.1007/s00402-020-03462-y. View

4.
Elliot-Gibson V, Bogoch E, Jamal S, Beaton D . Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int. 2004; 15(10):767-78. DOI: 10.1007/s00198-004-1675-5. View

5.
Dore A, Golightly Y, Mercer V, Shi X, Renner J, Jordan J . Lower-extremity osteoarthritis and the risk of falls in a community-based longitudinal study of adults with and without osteoarthritis. Arthritis Care Res (Hoboken). 2014; 67(5):633-9. PMC: 4404178. DOI: 10.1002/acr.22499. View